MedPath

Dopaminergic Functioning in Autism Spectrum Disorder

Recruiting
Conditions
Autism Spectrum DisorderAutisme Spectrum StoornisSocial DefeatSocial ExclusionSociale UitsluitingPsychosisPsychoseDopamine
Registration Number
NL-OMON21453
Lead Sponsor
GGZ Rivierduinen Leiden, Leiden University Medical Center (LUMC), Maastricht University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
69
Inclusion Criteria

1. Patients: DSM-5 diagnosis of Autism Spectrum Disorder.

2. Age: 18-30 years.

Exclusion Criteria

1. Healthy controls: DSM-5 diagnosis of Autism Spectrum Disorder.

2. Autism Spectrum Disorder due to a known organic disorder (¡°Syndromal ASD¡±, e.g., due to Fragile X syndrome, Klinefelter syndrome, 22q11 deletion syndrome).

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Relation between [18F]DOPA influx (Ki) value and total score on UCLA Loneliness Scale (v3) in non-psychotic individuals with ASD.<br /><br>2. The [18F]DOPA influx (Ki) value in non-psychotic individuals with ASD compared to the [18F]DOPA influx (Ki) value in healthy control participants.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath